Targeted Oncology,volume 6,issue 1  (03-2013)

Period of time： 2013年1期

Publisher： Springer Publishing Company

Founded in： 2006

Total resources： 10

ISSN： 1776-2596

Subject： R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Targeted Oncology,volume 6,issue 1

Menu

Targeting the target of rapamycin (TOR): looking to mother nature

By Rowinsky Eric in (2011)

Targeted Oncology,volume 6,issue 1 , Vol. 6, Iss. 1, 2011-03 , pp. 1-4

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

By Pal Sumanta in (2011)

Targeted Oncology,volume 6,issue 1 , Vol. 6, Iss. 1, 2011-03 , pp. 5-16

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Mechanisms of mTOR inhibitor resistance in cancer therapy

By Carew Jennifer in (2011)

Targeted Oncology,volume 6,issue 1 , Vol. 6, Iss. 1, 2011-03 , pp. 17-27

Springer Publishing Company

Abstract Access to resources Recommend Favorite

The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas

By Vemulapalli Sushma in (2011)

Targeted Oncology,volume 6,issue 1 , Vol. 6, Iss. 1, 2011-03 , pp. 29-39

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Aging and cancer: can mTOR inhibitors kill two birds with one drug?

By Sharp Zelton in (2011)

Targeted Oncology,volume 6,issue 1 , Vol. 6, Iss. 1, 2011-03 , pp. 41-51

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Mammalian target of rapamycin as a target in hematological malignancies

By Kelly Kevin in (2011)

Targeted Oncology,volume 6,issue 1 , Vol. 6, Iss. 1, 2011-03 , pp. 53-61

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Total 6 item(s)